Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2018	03-2018	12-2017	09-2017	06-2017
Assets
Current Assets
Cash & Cash Equivalents	39,282	69,212	282,896	56,323	54,195
Marketable Securities	194,452	199,594	N/A	97,117	111,852
Receivables	N/A	N/A	48	N/A	N/A
TOTAL	$242,882	$273,418	$285,211	$156,267	$174,353

Non-Current Assets
PPE Net	12,196	10,064	9,250	11,500	11,255
Other Non-Current Assets	4,045	1,298	1,238	1,416	1,468
TOTAL	$16,241	$11,362	$10,488	$12,916	$12,723

Total Assets	$259,123	$284,780	$295,699	$169,183	$187,076

Liabilities
Current Liabilities
Short Term Debt	N/A	983	1,872	2,727	3,550
Accounts payable and accrued liabilities	5,435	5,361	6,805	6,680	4,079
Accrued Expenses	13,569	11,120	12,225	12,069	14,347
TOTAL	$28,324	$22,996	$20,902	$21,476	$21,976

Non-Current Liabilities
Deferred Revenues	9,320	5,532	N/A	N/A	N/A
Other Non-Current Liabilities	2,717	2,647	2,613	2,233	2,189
TOTAL	$20,944	$25,143	$5,952	$5,651	$5,686

Total Liabilities	$49,268	$48,139	$26,854	$27,127	$27,662

Shareholders' Equity
Shares Outstanding, K	36,938	36,784	36,685	30,935	30,819
Common Shares	37	37	37	31	30
Retained earnings	-611,284	-577,204	-542,167	-506,261	-475,610
Other shareholders' equity	-224	-276	0	-43	-114
TOTAL	$209,855	$236,641	$268,845	$142,056	$159,414

Total Liabilities And Equity	$259,123	$284,780	$295,699	$169,183	$187,076